What is Macular degeneration?
Macular degeneration (MD) usually affects older adults and results in a loss of vision in the center of the visual field (the macula) because of damage to the retina. The dry form of MD occurs as a result of retinal atrophy; the wet form is due to leakage of blood or protein below the macula.
What do patients take to treat Macular degeneration and its symptoms?
Commonly prescribed and frequently used treatments
| Treatment name | Efficacy | Overall rating of side effects | # of Evaluations |
|---|---|---|---|
|
Bevacizumab
(Avastin)
|
1 | ||
|
Zinc
(Biocare Nutrisorb Zinc, Metagenics Zinc Drink, Chelated Zinc)
|
0 | ||
|
Vitamin E
(Vitamin E topical, Vitalady Tender Dry E, Whole Foods Vitamin E, Spring Valley Vitamin E)
|
0 | ||
|
Vitamin C (ascorbic acid)
(Usana PolyC-6, Esther-C, Natural Factors Vitamin C, WSN Vitamin C)
|
0 | ||
| 0 | |||
|
Vitamin A
(Beta-carotene, Retinol)
|
0 |
These charts show data from Macular degeneration patients' latest treatment evaluations
Who has Macular degeneration at PatientsLikeMe?
- 70 patients have this condition
- 6 New patients joined this month
- 22 say Macular degeneration is their primary condition
| <20 | 20-29 | 30-39 | 40-49 | 50-59 | 60-69 | 70+ |
|---|---|---|---|---|---|---|
| Current Age | ||||||
| Gender | |
| 62% | Females |
|---|---|
| 38% | Males |
| Age at first symptom | # of patients | Proportion |
|---|---|---|
| 0-19 yrs | 3 | |
| 20-29 yrs | 1 | |
| 30-39 yrs | 1 | |
| 40-49 yrs | 4 | |
| 50-59 yrs | 10 | |
| 60-69 yrs | 5 | |
| 70+ yrs | 1 |
| Diagnosis status | # of patients | Proportion |
|---|---|---|
| Diagnosed | 38 | |
| Not Officially Diagnosed | 5 |
These charts show data from Macular degeneration patients who have completed their condition history